HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surasak Phuphanich Selected Research

Surasak Phuphanich Research Topics

Disease

20Glioblastoma (Glioblastoma Multiforme)
01/2022 - 03/2002
17Glioma (Gliomas)
04/2020 - 09/2002
14Neoplasms (Cancer)
01/2022 - 05/2002
4Disease Progression
01/2022 - 11/2011
4Meningitis
01/2017 - 05/2002
4Brain Neoplasms (Brain Tumor)
06/2014 - 01/2003
2Astrocytoma (Pilocytic Astrocytoma)
04/2020 - 08/2008
2Lymphoma (Lymphomas)
01/2020 - 01/2007
1Oligodendroglioma
04/2020
1Microsatellite Instability
01/2020
1Residual Neoplasm
10/2019
1Radiculopathy (Radiculopathy, Cervical)
01/2017
1Peroneal Neuropathies
01/2017
1Meningioma (Meningiomas)
01/2015
1Seizures (Absence Seizure)
06/2013
1Headache (Headaches)
05/2012
1Necrosis
06/2010
1Fatigue
08/2008
1Rhinitis
08/2008
1Edema (Dropsy)
08/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2007
1Cerebellar Ataxia (Dysmetria)
01/2007
1Deglutition Disorders (Dysphagia)
01/2007
1Carcinoma (Carcinomatosis)
01/2007
1Leukemia
01/2007
1Ovarian Neoplasms (Ovarian Cancer)
01/2007
1Paraneoplastic Cerebellar Degeneration
01/2007
1Hodgkin Disease (Hodgkin's Disease)
09/2006
1Spinal Cord Diseases
09/2006
1Myelitis
09/2006
1Gliosarcoma
07/2006

Drug/Important Bio-Agent (IBA)

7Temozolomide (Temodar)FDA LinkGeneric
01/2020 - 01/2011
4VaccinesIBA
01/2022 - 01/2013
3ErbB Receptors (EGF Receptor)IBA
03/2015 - 07/2004
2Bevacizumab (Avastin)FDA Link
01/2020 - 01/2011
2Immune Checkpoint InhibitorsIBA
01/2020 - 01/2020
2Lomustine (CCNU)FDA Link
01/2016 - 09/2013
2cediranib (AZD2171)IBA
01/2016 - 09/2013
2Anticonvulsants (Antiepileptic Drugs)IBA
06/2013 - 04/2005
2EnzymesIBA
11/2011 - 08/2008
2LigandsIBA
06/2010 - 07/2007
2Carmustine (FIVB)FDA Link
12/2008 - 09/2002
2AtrasentanIBA
08/2008 - 07/2004
2LipidsIBA
07/2007 - 01/2007
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2007 - 05/2002
2Carboplatin (JM8)FDA LinkGeneric
01/2007 - 01/2003
24-phenylbutyric acid (Buphenyl)FDA Link
04/2005 - 09/2002
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2022
1poliferprosan 20 drug combination carmustine (Gliadel)FDA Link
04/2020
1N 30IBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1NivolumabIBA
01/2020
1TovetumabIBA
01/2017
1Platelet-Derived Growth FactorIBA
01/2017
1AfatinibIBA
03/2015
1epidermal growth factor receptor VIIIIBA
03/2015
1pasireotideIBA
01/2015
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2015
1verubulinIBA
06/2014
1Tyrosine Kinase InhibitorsIBA
09/2013
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2013
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2013
1LacosamideFDA Link
06/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2013
1Sorafenib (BAY 43-9006)FDA Link
04/2013
1GadoliniumIBA
01/2013
1Peptides (Polypeptides)IBA
01/2013
1EpitopesIBA
01/2013
1Neoplasm Antigens (Tumor Antigens)IBA
01/2013
1AntigensIBA
01/2013
1tetracycline CMT-3IBA
11/2011
1ixabepilone (BMS 247550)FDA Link
11/2010
1Bortezomib (Velcade)FDA Link
10/2010
1Caspase 8 (Caspase-8)IBA
06/2010
1CaspasesIBA
06/2010
1Interferon alpha-2 (Roferon-A)FDA Link
12/2008
1PolymersIBA
12/2008
1cositecanIBA
08/2008
1Endothelin A ReceptorIBA
08/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2007
1Anti-Idiotypic AntibodiesIBA
01/2007
1Liposomes (Liposome)IBA
01/2007
1SuspensionsIBA
01/2007
1Tumor Biomarkers (Tumor Markers)IBA
01/2007
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2007
1Paclitaxel (Taxol)FDA LinkGeneric
01/2007
1AntimetabolitesIBA
01/2007
1Procarbazine (Matulane)FDA Link
09/2006
1marimastatIBA
07/2006
1Metalloproteases (Metalloproteinases)IBA
07/2006
1Matrix Metalloproteinases (MMPs)IBA
07/2006

Therapy/Procedure

10Radiotherapy
10/2019 - 09/2002
8Therapeutics
01/2020 - 04/2004
3Drug Therapy (Chemotherapy)
09/2006 - 03/2002
1Intradermal Injections
04/2020
1Conservative Treatment
05/2012
1Combination Drug Therapy (Combination Chemotherapy)
01/2007
1Enteral Nutrition (Feeding, Tube)
01/2007